Oncolytics Biotech Inc.
ONCY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$31,710 | -$27,752 | -$24,835 | -$26,304 |
| Dep. & Amort. | $424 | $403 | $392 | $452 |
| Deferred Tax | $0 | $0 | $0 | $409 |
| Stock-Based Comp. | $2,723 | $2,068 | $2,378 | $3,826 |
| Change in WC | $3,538 | $1,765 | $391 | -$908 |
| Other Non-Cash | -$1,941 | -$4,932 | -$1,681 | $92 |
| Operating Cash Flow | -$26,966 | -$28,448 | -$23,355 | -$22,434 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$239 | -$8 | -$55 | -$286 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$20,348 | $0 |
| Inv. Sales/Matur. | $0 | $20,230 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$20 | $0 |
| Investing Cash Flow | -$239 | $20,222 | -$20,403 | -$286 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$348 | -$407 | -$381 | -$366 |
| Stock Issued | $6,919 | $31,620 | $12,574 | $32,912 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $65 | $781 | $12 | $470 |
| Financing Cash Flow | $6,636 | $31,994 | $12,205 | $33,016 |
| Forex Effect | $1,599 | -$522 | $1,957 | -$253 |
| Net Chg. in Cash | -$18,970 | $23,246 | -$29,596 | $10,042 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $34,912 | $11,666 | $41,262 | $31,220 |
| End Cash | $15,942 | $34,912 | $11,666 | $41,262 |
| Free Cash Flow | -$27,205 | -$28,456 | -$23,410 | -$22,720 |